288 related articles for article (PubMed ID: 19368137)
1. Intra-arterial hepatic chemoembolization (TACE) of liver metastases from ocular melanoma with slow-release irinotecan-eluting beads. Early results of a phase II clinical study.
Fiorentini G; Aliberti C; Del Conte A; Tilli M; Rossi S; Ballardini P; Turrisi G; Benea G
In Vivo; 2009; 23(1):131-7. PubMed ID: 19368137
[TBL] [Abstract][Full Text] [Related]
2. Intraarterial hepatic chemoembolization of liver metastases from colorectal cancer adopting irinotecan-eluting beads: results of a phase II clinical study.
Fiorentini G; Aliberti C; Turrisi G; Del Conte A; Rossi S; Benea G; Giovanis P
In Vivo; 2007; 21(6):1085-91. PubMed ID: 18210761
[TBL] [Abstract][Full Text] [Related]
3. TACE of liver metastases from colorectal cancer adopting irinotecan-eluting beads: beneficial effect of palliative intra-arterial lidocaine and post-procedure supportive therapy on the control of side effects.
Fiorentini G; Aliberti C; Benea G; Montagnani F; Mambrini A; Ballardini PL; Cantore M
Hepatogastroenterology; 2008; 55(88):2077-82. PubMed ID: 19260480
[TBL] [Abstract][Full Text] [Related]
4. Transarterial Chemoembolization of Liver Metastases from Uveal Melanoma Using Irinotecan-Loaded Beads: Treatment Response and Complications.
Carling U; Dorenberg EJ; Haugvik SP; Eide NA; Berntzen DT; Edwin B; Dueland S; Røsok B
Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1532-41. PubMed ID: 25832764
[TBL] [Abstract][Full Text] [Related]
5. Transarterial chemoembolization with drug-eluting beads preloaded with irinotecan as a first-line approach in uveal melanoma liver metastases: tumor response and predictive value of diffusion-weighted MR imaging in five patients.
Venturini M; Pilla L; Agostini G; Cappio S; Losio C; Orsi M; Ratti F; Aldrighetti L; De Cobelli F; Del Maschio A
J Vasc Interv Radiol; 2012 Jul; 23(7):937-41. PubMed ID: 22720894
[TBL] [Abstract][Full Text] [Related]
6. Transcatheter arterial chemoembolization (TACE) of colorectal cancer liver metastases by irinotecan-eluting microspheres in a salvage patient population.
Huppert P; Wenzel T; Wietholtz H
Cardiovasc Intervent Radiol; 2014 Feb; 37(1):154-64. PubMed ID: 23670568
[TBL] [Abstract][Full Text] [Related]
7. Preliminary experience with transarterial chemoembolization (TACE) in liver metastases of uveal malignant melanoma: local tumor control and survival.
Vogl T; Eichler K; Zangos S; Herzog C; Hammerstingl R; Balzer J; Gholami A
J Cancer Res Clin Oncol; 2007 Mar; 133(3):177-84. PubMed ID: 17021903
[TBL] [Abstract][Full Text] [Related]
8. Complete pathological response of unresectable liver metastases from colorectal cancer after trans-arterial chemoembolization with drug-eluting beads loaded with irinotecan (DEBIRI) and concomitant systemic FOLFOX: A case report from the FFCD 1201 trial.
Pernot S; Artru P; Mithieux F; Marsot J; Watkin E; Pellerin O; Lledo G; Chalabreysse P; Desramé J; Taieb J
Clin Res Hepatol Gastroenterol; 2015 Dec; 39(6):e73-7. PubMed ID: 26141343
[TBL] [Abstract][Full Text] [Related]
9. A retrospective analysis of 141 patients with liver metastases from uveal melanoma: a two-cohort study comparing transarterial chemoembolization with CPT-11 charged microbeads and historical treatments.
Valpione S; Aliberti C; Parrozzani R; Bazzi M; Pigozzo J; Midena E; Pilati P; Campana LG; Chiarion-Sileni V
Melanoma Res; 2015 Apr; 25(2):164-8. PubMed ID: 25521594
[TBL] [Abstract][Full Text] [Related]
10. Transarterial chemoembolization using DEBIRI for treatment of hepatic metastases from colorectal cancer.
Narayanan G; Barbery K; Suthar R; Guerrero G; Arora G
Anticancer Res; 2013 May; 33(5):2077-83. PubMed ID: 23645758
[TBL] [Abstract][Full Text] [Related]
11. Chemoembolization with drug eluting beads preloaded with irinotecan (DEBIRI) vs doxorubicin (DEBDOX) as a second line treatment for liver metastases from cholangiocarcinoma: a preliminary study.
Venturini M; Sallemi C; Agostini G; Marra P; Cereda S; Reni M; Aldrighetti L; De Cobelli F; Del Maschio A
Br J Radiol; 2016 Nov; 89(1067):20160247. PubMed ID: 27558984
[TBL] [Abstract][Full Text] [Related]
12. Trans-arterial chemoembolization of metastatic colorectal carcinoma to the liver adopting DC Bead®, drug-eluting bead loaded with irinotecan: results of a phase II clinical study.
Aliberti C; Fiorentini G; Muzzio PC; Pomerri F; Tilli M; Dallara S; Benea G
Anticancer Res; 2011 Dec; 31(12):4581-7. PubMed ID: 22199334
[TBL] [Abstract][Full Text] [Related]
13. Optimizing the treatment of liver metastases from uveal melanomas with transarterial chemoembolization using melphalan and calibrated microspheres.
Carle X; Gastaud L; Salleron J; Tardy MP; Caujolle JP; Thyss A; Thariat J; Chevallier P
Bull Cancer; 2020 Dec; 107(12):1274-1283. PubMed ID: 33183739
[TBL] [Abstract][Full Text] [Related]
14. Transarterial chemoembolization of liver metastases from uveal melanoma after failure of systemic therapy: toxicity and outcome.
Schuster R; Lindner M; Wacker F; Krössin M; Bechrakis N; Foerster MH; Thiel E; Keilholz U; Schmittel A
Melanoma Res; 2010 Jun; 20(3):191-6. PubMed ID: 20335820
[TBL] [Abstract][Full Text] [Related]
15. Fotemustine chemoembolization of hepatic metastases from uveal melanoma: a retrospective single-center analysis.
Edelhauser G; Schicher N; Berzaczy D; Beitzke D; Höeller C; Lammer J; Funovics M
AJR Am J Roentgenol; 2012 Dec; 199(6):1387-92. PubMed ID: 23169735
[TBL] [Abstract][Full Text] [Related]
16. Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results.
Aliberti C; Tilli M; Benea G; Fiorentini G
Anticancer Res; 2006; 26(5B):3793-5. PubMed ID: 17094403
[TBL] [Abstract][Full Text] [Related]
17. Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study.
Iezzi R; Marsico VA; Guerra A; Cerchiaro E; Cassano A; Basso M; Devicienti E; Rodolfino E; Barone C; Bonomo L
Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1523-31. PubMed ID: 25799948
[TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results.
de Baere T; Deschamps F; Teriitheau C; Rao P; Conengrapht K; Schlumberger M; Leboulleux S; Baudin E; Hechellhammer L
J Vasc Interv Radiol; 2008 Jun; 19(6):855-61. PubMed ID: 18503899
[TBL] [Abstract][Full Text] [Related]
19. Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy.
Kuhlmann JB; Euringer W; Spangenberg HC; Breidert M; Blum HE; Harder J; Fischer R
Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):437-43. PubMed ID: 22261548
[TBL] [Abstract][Full Text] [Related]
20. Hepatic Arterial Infusion of Polyethylene Glycol Drug-eluting Beads for Primary and Metastatic Liver Cancer Therapy.
Aliberti C; Carandina R; Sarti D; Mulazzani L; Catalano V; Felicioli A; Coschiera P; Fiorentini G
Anticancer Res; 2016 Jul; 36(7):3515-21. PubMed ID: 27354617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
